In June 2014 the Japan Anti-Doping Agency (JADA) has reported an anti-doping rule violation against the Athlete J-4066 (the Athlete) after her sample tested positive for the prohibited substance canrenone.
After notification a provisional suspension was ordered and the Athlete filed a statement in her defence.
The Athlete submitted, sustained by her doctor and medical record, that she had used a prescribed medication for her skin condition without intention to enhance her performance or to mask the use of a prohibited substance.
The Panel concludes that the Athlete’s acted with a certain level of negligence due to she failed to check the ingredients of the medication before using and did not mention to her doctor that she was an athlete.
Considering the circumstances the Japan Anti-Doping Disciplinary Panel decides on 23 July 2014 to impose a 3 month period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 16 June 2014.
